RSS   Newsletter   Contact   Advertise with us
Post Online Media

Immunocore appoints Paul Fry as chief financial officer

ImmunocoreImmunocore Limited, a biotechnology company, announces the appointment of Paul Fry as chief financial officer.

Mr. Fry joins Immunocore with over 20 years’ experience in senior positions in the life sciences and telecommunications sectors.

READ MORE Immunocore appoints Sir John Bell to its board

Prior to joining Immunocore he served as Director of Global Finance Operations at Vodafone Plc, where he was responsible for key financial controllership activities, core processes as well as large transformation projects and programmes.

Prior to joining Vodafone, Mr. Fry spent more than 25 years at GlaxoSmithKline, serving in a number of roles including Head of Global Finance Services and as CFO for GSK’s Italian Pharmaceutical business.

More recently he oversaw all of the financial aspects of the multibillion dollar transaction which saw GSK divest its oncology business in a transfer for Novartis Vaccines.


 LATEST MOVES FROM United Kingdom 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy